Treatment of type 2 diabetes with saxagliptin: a pharmacoeconomic evaluation in Argentina
Background: The increasing prevalence of diabetes and its inadequate management results in a heavy burden of the disease for the patients, the health and the productive system and the overall community. Consequently, it is necessary to have new effective drugs to treat people with diabetes to decrea...
Guardado en:
| Autores principales: | Elgart, Jorge Federico, Caporale, Joaquín Enzo, González, Lorena, Aiello, Eleonora, Waschbusch, Maximiliano, Gagliardino, Juan José |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/85367 |
| Aporte de: |
Ejemplares similares
-
Saxagliptin affects long-bone microarchitecture and decreases the osteogenic potential of bone marrow stromal cells
por: Sbaraglini, María Laura, et al.
Publicado: (2014) -
Diabetes in Argentina: Cost and management of diabetes and its complications and challenges for health policy
por: Caporale, Joaquín Enzo, et al.
Publicado: (2013) -
Evaluation of treatment adherence in patients with type 2 diabetes
por: Angeli , C, et al.
Publicado: (2021) -
Hospitalization costs for heart failure in people with type 2 diabetes: Cost-effectiveness of its prevention measured by a simulated preventive treatment
por: Caporale, Joaquín Enzo, et al.
Publicado: (2011) -
El coste de la diabetes tipo 2 en Espa�na el estudio CODE-2 /
por: Mata, M, et al.
Publicado: (2002)